Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Balance Sheet
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's total assets for Q3 2025 were ¥18.72B, an increase of 8.62% from the previous quarter. HK:9989 total liabilities were ¥5.14B for the fiscal quarter, a 2.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.